Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients

Bone Marrow Transplantation

Volumn 20, Issue 4, 1997, Pages 265-271

  Fernandez M ^a   Simon, V ^b   Herrera, G ^a   Cao, C ^b   Del Favero, H ^b   Minguell, J J ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b CLÍNICA LAS CONDES   (Chile)

Author keywords

Breast cancer; Growth factor; Mobilization; PBPC; Stromal cells

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BREAST CANCER; CELL TRANSPLANTATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; STEM CELL; STROMA CELL;

EID: 1842404184     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700890     Document Type: Article

References (31)

1. Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85: 1413-1415.
2. Schmitz N, Gratwohl A, Goldman J. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1996 and proposals for an operational classification. Bone Marrow Transplant 1996; 17: 471-477.
3. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood 1976; 47: 1031-1039.
4. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905-1914.
5. Chao NJ, Schriber JR, Grimes K et al. Granulocyte colony-stimulating factor 'mobilized' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993; 81: 2031-2035.
6. Peters WP, Rosner G, Ross M el al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993; 81: 1709-1719.
7. Sutherland HJ, Eaves CJ, Lansdorp PM et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808-3814.
8. + hemopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood. J Hematother 1993; 2: 483-489.
9. Fernández M, Minguell JJ. Adhesive interactions in the hematopoietic system: regulation by cytokines. Proc Soc Exp Biol Med 1996; 212: 313-323.
10. Orazi A, Cattoretti G, Schiró R et al. Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow. Blood 1992; 79: 2610-2619.
11. Dedhar S, Gaboury L, Galloway P et al. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. Proc Natl Acad Sci USA 1988; 85: 9253-9257.
12. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992; 13: 69-80.
13. Chichester CO, Fernández M, Minguell JJ. Extracellular matrix gene expression by human bone marrow stroma and by marrow fibroblasts. Cell Adhesion Commun 1993; 1: 93-99.
14. Lazarus HM, Haynesworth SE, Gerson SL et al Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16: 557-564.
15. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996; 166: 585-592.
16. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991; 78: 55-62.
17. Brandt J, Srour EF, van Besien K et al. Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest 1990; 86: 932-941.
18. Greenberger JD. The hematopoietic microenvironment. Crit Rev Oncol/Hematol 1991; 11: 65-84.
19. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
20. Siena S, Di Nicola M, Bregni M et al. Massive ex vivo generation of functional dendritic cells from mobilized CD34 blood progenitors for anticancer therapy. Exp Hematol 1995; 23: 1463-1471.
21. Suva MR, Parreira A, Ascensao JL. Natural killer cell number and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion. Exp Hematol 1995; 23: 1676-1681.
22. Ross AA, Cooper BW, Lazarus HM et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993; 82: 2605-2610.
23. Pereira RF, Halford KW, O'Hara MD et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 1995; 92: 4857-1861.
24. + fraction of adult human bone marrow contains the osteogenic precursors. Blood 1994; 84: 4164-4173.
25. Galmiche MC, Koteliansky VE, Briere J et al. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood 1993; 82: 66-76.
26. Wilkins BS, Jones DB. Inmunohistochemical characterization of intact stromal layers in long-term cultures of human bone marrow. Br J Haematol 1995; 90: 757-766.
27. Verfaillie C, Nurley R, Bhatia R et al. Role of bone marrow matrix in normal and abnormal hematopoiesis. Crit Rev Oncol/Hematol 1994; 16: 201-224.
28. Zipori D. Cultured stromal cell lines from hemopoietic tissues. In Tavassoli M (ed). Handbook of the Hemopoietic Microenvironment. Humana Press: Clifton, New Jersey, 1989, pp 287-329.
29. + hemopoietic progenitor cell. J lmmunol 1994; 153: 4673-4683.
30. Klein G, Muller CA, Tillet E et al. Collagen type VI in the human bone marrow microenvironment: a strong cytoadhesive component. Blood 1995; 86: 1740-1748.
31. Fernández M, Minguell JJ. G-CSF regulates the expression of mRNA for collagen type VI and collagen VI production in human bone marrow stromal cells. Hematology 1997 (in press).